Juhaeri Juhaeri, PhD

VP & Global Head, Epidemiology and Benefit - Risk
Sanofi, New Jersey, United States

Disclosure information not submitted.

Presentation(s):

• SC-06 - Weighing the Benefits & Risks: The Science and Methods of Benefit-Risk Assessment in Drug Development

  Friday, August 22, 2025
  9:00 AM - 12:30 PM ET

• SW-2D - The Future of Pharmacovigilance: Accelerating Signal Identification With Electronic Healthcare Data

  Sunday, August 24, 2025
  5:15 PM - 6:45 PM ET